This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DOJ Appeals Court Decision To Broaden Access To Emergency Contraception

WASHINGTON, May 2, 2013 /PRNewswire-USNewswire/ -- Statement by Susannah Baruch, Interim President & CEO of the Reproductive Health Technologies Project, on the Department of Justice's appeal of Judge Korman's ruling directing the FDA to approve over-the-counter access to emergency contraception for all women within 30 days.

"We are profoundly disappointed.  This appeal takes away the promise of all women having timely access to emergency contraception. 

"It is especially troubling in light of the Food and Drug Administration's move yesterday to continue age restrictions and ID requirements, despite a court order to make emergency contraception accessible for women of all ages.

"Both announcements, particularly in tandem, highlight the Administration's corner-cutting on women's health.  Complying with the thorough reasoning and clear directive of the court order would have been a huge step forward.  Instead, we are left wondering how many more years we will have to wait for science to prevail.

"For years, medical experts, including scientists at the Food & Drug Administration, American Academy of Pediatrics, and American Congress of Obstetricians and Gynecologists, have agreed that emergency contraception is safe for over-the-counter use by women of all ages and should be on store shelves.  Without requiring women to prove their age; without the public embarrassment that can come from being "carded" by a clerk and without putting women who don't have identification -- whether because they are pre-driver's license or because they are immigrants, or because they simply forgot to bring their ID when they left the house in a rush -- in a continued race against the clock.

"[The Administration is under a court order to fix the mistakes they have made in the past. Instead they are taking the path of least resistance, a half-solution to a real problem.]

"Today it is clear that the only thing stronger than the scientific evidence supporting the removal of the point of sale restrictions on emergency contraception is political interference with robust agency decision-making.  Judge Korman meticulously documented both in his April 5 th ruling.

"It's a sad day for women's health when politics prevails.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,683.58 -46.53 -0.26%
S&P 500 2,068.76 -8.02 -0.39%
NASDAQ 4,991.94 -17.2740 -0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs